Search research articles
Contact Us
Filters
Showing results (201-210 of 332) with videos related to
Page
of 34
Sort By:
Neurobiology of Disease
|
March 5, 2013
Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury
David Tweedie, Lital Rachmany, Vardit Rubovitch, et al.
Journal of Clinical Medicine
|
August 12, 2023
A Comprehensive Review on Neuroendocrine Neoplasms: Presentation, Pathophysiology and Management
Qamar Sultana, Jill Kar, Amogh Verma, et al.
Frontiers in Neuroscience
|
April 15, 2021
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
Yoo Jin Jung, David Tweedie, Michael T Scerba, et al.
Frontiers in Aging Neuroscience
|
March 3, 2020
Neuroprotection by the Immunomodulatory Drug Pomalidomide in the <i>Drosophila</i> LRRK2<sup>WD40</sup> Genetic Model of Parkinson's Disease
Maria Antonietta Casu, Ignazia Mocci, Raffaella Isola, et al.
Plos One
|
February 6, 2013
Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease
Anna M Lilja, Yu Luo, Qian-sheng Yu, et al.
Age (Dordrecht, Netherlands)
|
August 16, 2012
Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice
Lital Rachmany, David Tweedie, Yazhou Li, et al.
Cell Transplantation
|
June 11, 2019
(-)-Phenserine Ameliorates Contusion Volume, Neuroinflammation, and Behavioral Impairments Induced by Traumatic Brain Injury in Mice
Shih-Chang Hsueh, Daniela Lecca, Nigel H Greig, et al.
Journal of Medicinal Chemistry
|
November 1, 2002
Novel p53 inactivators with neuroprotective action: syntheses and pharmacological evaluation of 2-imino-2,3,4,5,6,7-hexahydrobenzothiazole and 2-imino-2,3,4,5,6,7-hexahydrobenzoxazole derivatives
Xiaoxiang Zhu, Qian-Sheng Yu, Roy G Cutler, et al.
Current Alzheimer Research
|
December 24, 2013
Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway
Marcella Reale, Marta Di Nicola, Lucia Velluto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 24, 2019
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease
Laura Boi, Augusta Pisanu, Nigel H Greig, et al.
Page
of 34
Search research articles
Search
Showing results (201-210 of 332) with videos related to
Sort By:
Page
of 34
Neurobiology of Disease
|
March 5, 2013
Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury
David Tweedie, Lital Rachmany, Vardit Rubovitch, et al.
Journal of Clinical Medicine
|
August 12, 2023
A Comprehensive Review on Neuroendocrine Neoplasms: Presentation, Pathophysiology and Management
Qamar Sultana, Jill Kar, Amogh Verma, et al.
Frontiers in Neuroscience
|
April 15, 2021
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
Yoo Jin Jung, David Tweedie, Michael T Scerba, et al.
Frontiers in Aging Neuroscience
|
March 3, 2020
Neuroprotection by the Immunomodulatory Drug Pomalidomide in the <i>Drosophila</i> LRRK2<sup>WD40</sup> Genetic Model of Parkinson's Disease
Maria Antonietta Casu, Ignazia Mocci, Raffaella Isola, et al.
Plos One
|
February 6, 2013
Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease
Anna M Lilja, Yu Luo, Qian-sheng Yu, et al.
Age (Dordrecht, Netherlands)
|
August 16, 2012
Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice
Lital Rachmany, David Tweedie, Yazhou Li, et al.
Cell Transplantation
|
June 11, 2019
(-)-Phenserine Ameliorates Contusion Volume, Neuroinflammation, and Behavioral Impairments Induced by Traumatic Brain Injury in Mice
Shih-Chang Hsueh, Daniela Lecca, Nigel H Greig, et al.
Journal of Medicinal Chemistry
|
November 1, 2002
Novel p53 inactivators with neuroprotective action: syntheses and pharmacological evaluation of 2-imino-2,3,4,5,6,7-hexahydrobenzothiazole and 2-imino-2,3,4,5,6,7-hexahydrobenzoxazole derivatives
Xiaoxiang Zhu, Qian-Sheng Yu, Roy G Cutler, et al.
Current Alzheimer Research
|
December 24, 2013
Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway
Marcella Reale, Marta Di Nicola, Lucia Velluto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 24, 2019
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease
Laura Boi, Augusta Pisanu, Nigel H Greig, et al.
Page
of 34